Pharmaceutical industry
The latest news relating to the pharmaceuticals industry, including regulation, litigation, business news and relevant industrial and academic research, from the Royal Society of Chemistry's magazine, Chemistry World
-
BusinessUS FDA commissioner Makary resigns amid chaos and questions
Marty Makary’s departure, amid reports that Trump planned to fire him, is the result of an ‘inherited crisis’ and ‘shifting FDA standards’, BIO says
-
OpinionIran war’s global impact keeps growing
Shortages of bitumen, cooking gas and jet fuel are pushing up prices and disrupting construction
-
ArticleAdvantages of monodisperse PEG in drug development
Precision matters: why monodisperse PEG is transforming drug development.
-
OpinionPurdue Pharma’s opioid prosecution enables bankruptcy settlement
$5 billion criminal sentence paves the way for resolution of civil liabilities through bankruptcy court
-
Business‘Basic research is needed more than anything else’
Christian Hackenberger, co-founder of Tubulis, is excited that his team’s initial research is now creating clinical impact
-
OpinionMajor drug regulators advancing routes to reduce animal testing
US, UK and EU all have goals to eliminate animal testing
-
FeatureThe curious case of disappearing polymorphs
From crystallographers’ beards to billion-dollar lawsuits, the phenomenon of disappearing polymorphs has puzzled chemists for decades. Now researchers are finally unravelling the science behind why stable crystal forms suddenly vanish – and discovering how to bring them back
-
OpinionIndia’s generic semaglutide surge
As patents on Novo Nordisk’s diabetes and weight loss blockbusters expire, generic makers have their versions ready
-
BusinessHow to choose reactor materials and test for compatibility
Merck & Co team describes simple testing strategies and criteria for decision-making
-
Opinion‘The truth is supremely valuable and we cannot lie our way to it’
As a scientist with family in Iran, Derek Lowe finds his own government’s approach to truth alarming
-
BusinessBoron plays a key role in new sleeping sickness drug
Acoziborole is the first single-dose treatment for both early and late stage sleeping sickness
-
WebinarTaking the sting out of pain: how marine venoms can be used to heal
Learn how marine venoms are being used to treat chronic pain
-
OpinionModerna’s vaccine regulatory hokey-cokey
US FDA initially refused to accept flu vaccine for review, but has since reversed that decision
-
WebinarHigh‑throughput retrosynthesis for real‑world chemistry
Discover how retrosynthesis software, paired with application programming interfaces, can accelerate route design, virtual screening and practical synthesis decisions
-
OpinionSlimming down competition over weight-loss drugs
Legal battle between Novo Nordisk and US compounding pharmacy Hims & Hers has fizzled after regulator intervention
-
ResearchWorld first for clinical trial of skin patch to monitor therapeutic drugs in real time
Sensor could soon help doctors to prevent overdoses of drugs
-
OpinionIs it cold in here?
Labs in Delhi, Aberdeen and Arizona will have different ideas of ‘room temperature’
-
NewsIn 2023, the UK was the first country to approve a Crispr therapy. How’s it doing?
Disconnect exists between the media hype around gene-editing treatment and the reality for patients
-
OpinionTrump’s attack on science is shaking industry’s foundations
By dismantling scientific enterprise, the US risks ‘taking a hammer to our miracle machine’
-
